Skip to main content
. 2015 May 29;6(21):18631–18640. doi: 10.18632/oncotarget.4072

Figure 2. Serum miR-26a is a potential diagnostic biomarker for CCA patients.

Figure 2

A. Serum miR-26a yielded an area under the curve (AUC) value of 0.899, with 84.8% sensitivity and 81.8% specificity in distinguishing CCA from normal control subjects. B. Comparison of serum miR-26a levels from all CCA patients (n = 66). C. Comparison of serum miR-26a levels in 48 CCA patients who underwent potentially curative surgeries. D. Comparison of serum miR-26a in 18 CCA patients who underwent palliative resections. Two-tailed Student's t test was used to analyze the significant differences. *P < 0.05.